# Health Catalyst Capital Annex Fund II, L.P. — Form D

Health Catalyst Capital Annex Fund II, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-12-06. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2024-12-06
- Form: D
- Accession: 0001012975-24-000515
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $4.0M
- Amount sold: $4.0M
- Minimum investment: $4.0M
- Investors: 1
- Date of first sale: 2024-11-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-531283

## Issuer

- Name: Health Catalyst Capital Annex Fund II, L.P.
- CIK: 0002046335
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 515 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: 212-752-2226

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| N/A Health Catalyst Associates Annex, LLC | Director | New York, NY |
| Charles Boorady | Executive Officer | Brentwood, TN |
| Daniel Ross | Executive Officer | Provo, UT |

## More

- [CIK 2046335 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2046335&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001012975-24-000515.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.